Rapid Micro Biosystems (NASDAQ:RPID) Upgraded by Wall Street Zen to Hold Rating

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $8.00.

Rapid Micro Biosystems Stock Up 2.6%

Shares of RPID stock opened at $3.91 on Friday. The firm’s fifty day moving average price is $3.66 and its two-hundred day moving average price is $3.40. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. Rapid Micro Biosystems has a 1 year low of $1.86 and a 1 year high of $4.94. The firm has a market capitalization of $173.29 million, a P/E ratio of -3.87 and a beta of 1.38.

Insider Activity

In other Rapid Micro Biosystems news, major shareholder Longitude Capital Partners Ii, sold 49,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $3.88, for a total value of $190,120.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Robert G. Jr. Spignesi sold 12,840 shares of Rapid Micro Biosystems stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $3.78, for a total transaction of $48,535.20. Following the sale, the chief executive officer directly owned 962,097 shares of the company’s stock, valued at $3,636,726.66. The trade was a 1.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 153,716 shares of company stock valued at $635,998 over the last quarter. 29.96% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Rapid Micro Biosystems

Several institutional investors and hedge funds have recently made changes to their positions in the company. Hudson Bay Capital Management LP acquired a new stake in shares of Rapid Micro Biosystems during the third quarter worth $38,000. American Century Companies Inc. raised its holdings in Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after acquiring an additional 5,341 shares in the last quarter. Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Rapid Micro Biosystems during the 4th quarter valued at $72,000. XTX Topco Ltd bought a new stake in shares of Rapid Micro Biosystems during the second quarter worth $144,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Rapid Micro Biosystems during the fourth quarter worth $160,000. Institutional investors and hedge funds own 52.60% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.